Pharmacytimes: Condition Center: CNS http://www.pharmacytimes.com/condition-resources/cns/condition-rss CNS en-us Sat, 23 Jun 2018 11:58:13 UTC Sat, 23 Jun 2018 11:58:13 UTC New Treatment for Phenylketonuria Approved by FDA http://www.pharmacytimes.com/news/new-treatment-for-phenylketonuria-approved-by-fda Novel enzyme therapy for adults with PKU, a rare genetic disease, has won approval from the agency. 7:00 PM, Thu May 24, 2018 EXPEDITION 3 Study: Is It Really a Failure? http://www.pharmacytimes.com/contributor/david-kim/2018/04/expedition-3-study-is-it-really-a-failure Solanezumab did not significantly affect cognitive decline compared with the placebo in subjects with mild Alzheimer&#39;s, but there are still takeaways. 2:06 AM, Thu April 26, 2018 CDC Report: Epilepsy Rates Increasing Among Adults and Children http://www.pharmacytimes.com/publications/issue/2018/March2018/cdc-report-epilepsy-rates-increasing-among-adults-and-children For the first time, epilepsy rate estimates have been available for every state, totaling at least 3.4 million individuals living with the disorder. 2:00 PM, Mon April 2, 2018 Let's Talk About Parkinson's Disease http://www.pharmacytimes.com/contributor/jerry-barbee-jr/2018/04/parkinson-disease--overview April is Parkinson&#39;s Disease awareness month, spotlighting this disorder of the central nervous system that affects movement. 8:00 AM, Mon April 2, 2018 Let's Talk About Multiple Sclerosis http://www.pharmacytimes.com/contributor/jerry-barbee-jr/2018/03/lets-talk-about-multiple-sclerosis <hr />March is MS awareness month, spotlighting this chronic, progressive disease that is growing in prevalence. 8:00 AM, Thu March 1, 2018 8 Multiple Sclerosis Studies Pharmacists Should Know About, Part 1 http://www.pharmacytimes.com/contributor/timothy-o-shea/2018/01/4-multiple-sclerosis-studies-pharmacists-should-know-about-part-1 A number of landmark clinical studies in the field of MS have been published, shaping how the disease is treated. 3:15 AM, Thu January 18, 2018 Perspectives for the Pharmacist in Epilepsy Management: Considerations for the Use of FYCOMPA(R) (perampanel) Tablets and Oral Suspension, CIII http://www.pharmacytimes.com/publications/issue/2017/September2017/R867_September2017 10:27 AM, Wed September 13, 2017 Amino Acid L-Serine in Preventing Neurodegenerative Diseases Associated with BMAA http://www.pharmacytimes.com/contributor/adam-remick/2017/09/amino-acid-l-serine-in-preventing-neurodegenerative-diseases-associated-with-bmaa Insights into possible treatments for disorders that range from demyelination to plaque formation and misfolded proteins. 9:41 PM, Mon September 4, 2017 CDC: Epilepsy Rates Increasing Among Adults, Children http://www.pharmacytimes.com/news/cdc-epilepsy-rates-increasing-among-adults-children For the first time, epilepsy rate estimates have been available for every state, totaling in at least 3.4 million individuals living with the disorder. 10:51 AM, Wed August 23, 2017 Epileptic Patients Face Heightened Suicide Risk http://www.pharmacytimes.com/publications/issue/2017/March2017/epileptic-patients-face-heightened-suicide-risk Patients with epilepsy are more likely to commit suicide than individuals without the condition, according to the results of a recent CDC study. 3:47 PM, Mon March 20, 2017 Antipsychotic Drugs Could Increase Mortality in Parkinson's Disease Patients http://www.pharmacytimes.com/publications/issue/2017/March2017/antipsychotic-drugs-could-increase-mortality-in-parkinsons-disease-patients Antipsychotic medications may do more harm than good in patients with Parkinson&rsquo;s disease, with a recent study indicating that the use of these drugs can lead to a heightened mortality risk in this population. 3:47 PM, Mon March 20, 2017 Early Treatment of MS Signs May Slow Disease Progression http://www.pharmacytimes.com/publications/issue/2017/March2017/early-treatment-of-ms-signs-may-slow-disease-progression A recent study has suggested that starting patients on multiple sclerosis medication soon after they show initial signs of the disease could prolong the time before the condition becomes fully diagnosable. 3:47 PM, Mon March 20, 2017 Epilepsy: What You and Your Patients Need to Know http://www.pharmacytimes.com/publications/issue/2017/March2017/epilepsy-what-you-and-your-patients-need-to-know The year 2016 was big for neurology, particularly in the realm of epilepsy. 1:08 PM, Mon March 20, 2017 Self-Care for Central Nervous System Function http://www.pharmacytimes.com/publications/issue/2017/March2017/selfcare-for-central-nervous-system-function Which OTC products should these pharmacists recommend? 12:03 PM, Mon March 20, 2017 What Role Do Zebrafish Models Play in Epilepsy Treatment? http://www.pharmacytimes.com/news/what-role-do-zebrafish-models-play-in-epilepsy-treatment Scientists have discovered a potential new drug therapy by using a zebrafish model of epilepsy.&nbsp; 9:00 AM, Tue February 14, 2017 Eisai Begins 2 Phase 3 Trials to Further Assess FYCOMPA http://www.pharmacytimes.com/product-news/eisai-begins-2-phase-3-trials-to-further-assess-fycompa- Eisai announced the beginning of 2 multi-center, global phase 3 clinical trials&nbsp;assessing FYCOMPA (perampanel). 7:00 AM, Wed November 2, 2016 A Brief Review of Brand-Name Antiepileptic Drugs http://www.pharmacytimes.com/contributor/mel-seabright-pharmd-mba/2016/05/a-brief-review-of-brand-name-antiepileptic-drugs Epilepsy is a brain disorder that predisposes an individual to recurrent unprovoked seizures. 4:17 AM, Wed May 18, 2016 New Fycompa Oral Suspension Formulation Receives FDA Approval http://www.pharmacytimes.com/contributor/anyssa-garza/2016/05/new-fycompa-oral-suspension-formulation-receives-fda-approval Initially approved in tablet form in 2012, perampanel (Fycompa) is now available as an oral suspension. 10:04 PM, Tue May 17, 2016 Self-Care for Disorders Related to the Central Nervous System http://www.pharmacytimes.com/publications/issue/2016/March2016/Self-Care-for-Disorders-Related-to-the-Central-Nervous-System Which OTC products should these pharmacists recommend? 10:30 PM, Mon March 14, 2016 More Women with Epilepsy Should Consider Contraceptives http://www.pharmacytimes.com/resource-centers/womens-health/more-women-with-epilepsy-should-consider-contraceptives Because many antiepileptic drugs have teratogenic potential, health care providers commonly recommend contraceptives to women with epilepsy. 9:37 PM, Mon March 7, 2016